Long-Term Fosamax Side Effects to be Reviewed by FDA Panel This Week
An FDA advisory panel is scheduled to meet this week to review the potential risks associated with long-term use of Fosamax and other bisphosphonate medications, which have been linked to a potential risk of spontaneous femur fractures and a rare jaw bone condition, known as osteonecrosis of the jaw (ONJ).
At meetings set to begin on Friday, a panel of outside experts will review whether the FDA should adjust the length of time Fosamax and other similar drugs are used or whether users should be required to take a “drug holiday” to reduce the risk of the serious and potentially debilitating problems associated with long-term use.
Although Fosamax is designed to strengthen the bones and reduce the risk of fractures associated with osteoporosis, long-term Fosamax side effects have been linked to decay of the jaw bone and reports of rare femur fractures.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Osteonecrosis of the jaw, which is also known as ONJ or jaw necrosis, can be caused when side effects of Fosamax and other bisphosphonates interrupt the flow of blood to the jaw. This can lead to the deterioration or death of the jaw bone, which may result in the need for surgery to remove portions of the jaw. As the drug is used over long periods of time, it can build up within the body, increasing the risk of the painful and disfiguring jaw problems developing.
In recent years, long term use of bisphosphonate medications has also been linked to an increased risk of bone fractures, as a growing number of people have reported suffering spontaneous and unexplained femur fractures on Fosamax, which often occur with little or no trauma at all. Side effects of Fosamax may weaken the ability of the femur bone to repair itself from microdamage, increasing the risk of a sudden femur fracture.
In October 2010, the FDA required new warnings about the risk of thigh fractures from Fosamax and other bisphosphonate medications. During a review of the potential Fosamax side effects, the FDA determined that the risk of fractures of the thigh bone may be connected to long-term use of bisphosphonates.
Merck & Co. currently faces hundreds of Fosamax jaw decay lawsuits and Fosamax bone fracture lawsuits that have been filed by individuals who claim the drug maker failed to adequately warn about the potential side effects.
Although the recommendations of the advisory panel will not be binding on the FDA, the agency is usually influenced significantly by the outside experts that are convened to review safety concerns.
MargaretOctober 4, 2011 at 2:54 pm
I took Fosamax quite a few years ago,then the Dr. changed it to something else,and then it was changed to Alendronate which I am still taking.I fell on Aug.31,2011 and broke my femur which has had a rod put in.I am still recovering.
"*" indicates required fields
More Top Stories
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.